LEP and depressive disorder: In addition, Metabolic dysfunction, including inflammation, insulin resistance, hypothalamic–pituitary–adrenal (HPA) axis dysregulation and central leptin resistance, have emerged as key risks to depression and anxiety development (7, 29, 30).